Medication leaflets

Active substance

Results for the substance riociguat

5 results

About this active substance

Riociguat is a medication used for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). It works by stimulating soluble guanylate cyclase, relaxing blood vessels and reducing pulmonary arterial pressure.

The medication is taken orally, as directed by a doctor, usually three times daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.

Patients should be aware of potential side effects, such as dizziness, nausea, or hypotension. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, nausea, and hypotension. In rare cases, severe reactions such as hemoptysis or heart failure may occur. Patients should be informed of these risks before starting treatment.